Search Results
Site Search
Check out how Mayo Clinic Laboratories’ digital pathology initiative integrates digital infrastructure to deliver digital workflows for patients to improve overall care.
Frequently asked questions - Insights
Check out how chromosomal microarray testing at Mayo Clinic Laboratories can help optimize treatment for neurological tumors.
Membranous nephropathy - Insights
Membranous nephropathy (MN) is one of the leading causes of nephrotic syndrome in adults. Our menu of clinically validated assays assists with diagnosis, monitors disease progression, and guides clinical outcomes.
Learn more Mayo Clinic Laboratories robust menu of newborn screening testing, which includes both primary and second-tier biochemical and molecular evaluations.
One Test, Multiple Targets: Zeroing in on Autoimmune Movement Disorders - Insights
A movement disorder might be caused by the body’s immune system, which is meant to fight infections, suddenly attacking the brain. Fortunately, an “autoimmune movement disorder” can often be treated—once its cause is discovered.
Mayo Clinic Laboratories has launched a first-in-the-U.S. autoimmune test of the Kelchlike protein 11 antibody, or KLHL11, which is used to detect autoimmune disease associated with testicular cancer.
What the Patient Considers When Choosing a Laboratory - Insights
Patients want to use a laboratory that is easy to work with, and there are different definitions of “easy.” Ultimately, health systems want to have the patients they serve use their health system laboratories. If patients are choosing to go...
Solutions for Common Service Recovery Challenges - Insights
Despite our best efforts, customer service failures do happen, but good service recovery tools can turn failures into positive customer experiences.
Focused Pharmacogenomics Panel [Test in Focus] - Insights
Ann Moyer, M.D., Ph.D., explains Mayo Clinic Labs’ new focused pharmacogenomics panel, a real-time, PCR-based testing approach that assesses 10 genes known for their drug-gene associations, to provide guidance on medication selection for...
Pathways Case Studies: September 2023 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for September include the following sub-specialties: Cardiovascular Pathology,...
Mayo Clinic researchers identify new disease subtype linked to recurrent blood clots - Insights
Mayo Clinic researchers identify a new subtype of MGTS, linked to recurrent blood clots, with significant diagnostic challenges and treatment implications.
b-lymphoblastic_leukemia-lymphoma_algorithm.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 04/2025 B-Lymphoblastic Leukemia/Lymphoma Genetic Testing Guidelines *For patients being considered for enrollment in Children’s Oncology Group (COG)...
April 2023 - Gynecological Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Gynecological Pathology.
epilepsy_unexplained_refractory_and_or_familial_testing_algorithm.pdf
Unexplained refractory and/or suspect familial epilepsy: All patients should have completed ■ Magnetic resonance imaging (MRI) ■ Electroencephalogram Consider: metabolic or autoimmune testing based on clinical presentation (see...
Mayo Clinic Labs @Work: Daniel Kronemann - Insights
As a clinical laboratory technologist, Daniel Kronemann enjoys going beyond his day-to-day work as he explores new ways to enhance processes and systems in Bacteriology.
For people with encephalitis, rapid treatment of their acute brain inflammation is critical for avoiding devastating physical and cognitive deficits. But appropriate treatment requires identifying the culprit causing the symptoms.
Collaboration Paves the Way for Rapid Discovery in Autoimmune Neurology - Insights
Using advanced technology, scientists at Chan Zuckerberg (CZ) Biohub, Mayo Clinic and University of California, San Francisco (UCSF), have discovered an autoimmune disease that appears to affect men with testicular cancer.
Update on 2021 WHO classification of lung tumors - Insights
In this month’s “Hot Topic,” Anja Roden, M.D., discusses new entities and changes of terminology in the 2021 World Health Organization (WHO) classification of lung tumors as well as the nomenclature in small biopsies.
Gadolinium-based contrast agents (GBCAs) have revolutionized MRIs by increasing the clinical utility and detection sensitivity of these exams. GBCAs also contain gadolinium, a rare earth metal with unique chemical properties. This article...
Pathways Case Studies: May 2023 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for May include the following sub-specialties: Cytopathology, Gastroenterology...
Justin Fugelsang and Zach Pedowitz have never met. Yet both young men were diagnosed with a rare form of Charcot-Marie-Tooth disease, called sorbitol dehydrogenase (SORD) deficiency, and both found clarity through Mayo Clinic Laboratories'...
JoAnne Michael’s symptoms started with dizziness and forgetfulness before down spiraling into severe confusion, crying jags, and brain seizures. ER doctors at her local hospital initially thought she was on drugs. JoAnne, terrified,...
Personalized medicine represents unprecedented potential benefits for patients. LabConnect and Mayo Clinic BioPharma Diagnostics are working together to bring world-class laboratory testing and resources to industry partners conducting...
According to Mayo Clinic research published in JAMA, six genes contain mutations that may be passed down in families, substantially increasing a person’s risk for pancreatic cancer.
Week in Review: April 21 - Insights
Top highlights include: Millions expected to lose dental care coverage, overdose deaths of elderly on the rise, and Minnesota Health Department urges caution for well owners as flood waters rise.
Black History Month: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to honor Black...
Industry Updates From the Nation's Capital: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss...
Week in Review: January 13 - Insights
Topic highlights include: With attention to mpox fading, health officials fear infections will go undetected and unreported, As COVID surges in China, US begins testing more travelers, FDA approves Alzheimer's drug that appears to modestly...
Supporting a Culture of Being "Color Brave" - Insights
In this sketchnote, Kulleni Gebreyes, M.D., discusses the role of race and cultivating a culture of being "color brave." She calls on us to be reflective and curious about our interactions to build awareness of our own biases and...
A Development Framework for Emerging and New Leaders - Insights
Amy Seegmiller-Renner, Education Coordinator and Assistant Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic, discusses a development framework for emerging and new leaders.
Mayo Medical Laboratories Rebrands Its Name as Mayo Clinic Laboratories - Insights
Mayo Medical Laboratories, the global reference laboratory of Mayo Clinic, has changed its name to Mayo Clinic Laboratories.
William Morice, II, M.D., Ph.D., Featured in "Minnesota Healthcare News" - Insights
William Morice, II, M.D., Ph.D., Chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota, and President of Mayo Medical Laboratories, was recently profiled in Minnesota Healthcare News.
Since the pandemic hit, she's spent a great deal of time vetting antibody tests and has set up a COVID-19 testing program at Mayo Clinic.
Will Laxen Receives Mayo Clinic Individual Award for Service Excellence - Insights
Will Laxen, Clinical Laboratory Technologist in the Biochemical Genetics Laboratory, was recently awarded the Mayo Clinic Individual Award for Service Excellence for his continuous commitment to quality and service.
Maria Alice Willrich, Ph.D., Discusses Therapeutic Monoclonal Antibodies - Insights
Maria Alice Willrich, Ph.D., was featured in an article in "360Dx" discussing therapeutic monoclonal antibodies (t-mAbs).
Bobbi Pritt, M.D., Advises Pathologists on Parasite Identification - Insights
Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory and Co-Director of Vector-Borne Diseases Lab Services in Mayo Clinic’s Department of Laboratory Medicine and Pathology, was recently featured in an article in CAP TODAY...
The Platform Transformation of Healthcare: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the...
Using metal detectors to ward off wayward specimens - Insights
To safeguard patient samples, staff in Mayo Clinic’s Histology Laboratory devised an inventive way to ensure that none of the paraffin-embedded blocks processed in the lab ever ends up in the trash.
Yuma Regional Medical Center: Strategic expansion to serve a growing community - Insights
Faced with a population increase and the need to expand both laboratory testing capacity and capabilities, Yuma Regional Medical Center leaned into its relationship with Mayo Clinic Laboratories to gain insights to strengthen community...
Mayo Clinic Team to Combat Arboviruses and Future Infectious Disease Threats in Belize - Insights
Mayo Clinic and the University of Notre Dame’s Eck Institute for Global Health have launched a four-tiered joint project to better characterize and further assist in the detection of vector-borne infectious diseases in Belize.
Monoclonal Gammopathy Informative Cases - Insights
Mayo Clinic Laboratories provides evaluation and consultation for the diagnosis and treatment of patients with hereditary and acquired hematologic disorders.
Top Gun Phlebotomy - Butterfly Use: The Good, the Bad, and the Ugly - Insights
In this month’s “Hot Topic,” Brad Karon, M.D., Ph.D., will discuss recent information on the advantages and disadvantages of using butterfly needles for blood collection.
Join us: Classical Hematology Conference 2024 - Insights
Presented by Mayo Clinic Laboratories, the Classical Hematology Conference, happening Oct. 15–17, is an essential event for professionals in hematology, including medical practitioners, researchers, and laboratory specialists.
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.